Moderna eyes combined Covid-19, flu booster by 2023
Moderna CEO Stéphane Bancel also said an Omicron-specific Covid-19 vaccine will enter clinical development in a matter of weeks.
By
UK News
Latest in
UK News
Medlab receives grant to develop NanoCelle nasal vaccine for Covid-19
The company will collaborate with the University of NSW and Macquarie University for vaccine development.
Molnupiravir: Merck’s Covid-19 antiviral less effective in new analysis
Updated data on molnupiravir shows the drug reduces hospitalisation or death by 30%, down from the initially reported 50% efficacy.
By
Biomanufacturers are facing persistent malware attacks, says cybersecurity group
The cyberattack, named Tardigrade, has been identified at two different biomanufacturing facilities.
By
Vaccibody rebrands to Nykode and bags $925m deal with Regeneron
Norwegian vaccine and immunotherapy-focused biopharma Vaccibody has rebranded to Nykode after signing a nearly $1bn deal.
By
UK grants world-first approval to Covid-19 pill molnupiravir
Molnupiravir is the first oral antiviral medication to be approved for the treatment of Covid-19.
By
UK government secures two Covid-19 antivirals ahead of winter
The purchase of Merck and Pfizer’s Covid-19 pills comes as coronavirus cases and hospitalisations rise across the country.
By
Moderna to build $500m vaccine manufacturing facility in Africa
The company plans to build a factory capable of producing up to 500 million vaccine doses in the continent each…
By